Omicron has a significant growth advantage over delta, leading to rapid. Based on the currently available evidence, the overall risk related to omicron remains very high. Omicron appears to show preference for infecting and replicating in the upper respiratory tract, compared to delta and other strains which prefer the lower respiratory tract.
While omicron was less severe compared to delta, there were still a significant number of deaths due to this variant worldwide. The variant was given the name omicron. Considering the available evidence, the additional public.